GSK plc - Wikipedia
GSK to create up to 5,000 jobs as it plans huge biotech centre | Financial Times
GSK to buy Bellus for $2 billion to gain cough medicine - Times of India
GSK lines up Rs 6,400cr open offer - Times of India
GSK's drugs arm to get $11 bln booster from consumer spin-off | Reuters
Financial Ratio Analysis of AstraZeneca and GlaxoSmithKline
GlaxoSmithKline : Top 20 Pharmaceutical Companies in 2021 | Contract Pharma
GSK to buy US biotech group Affinivax in $3bn deal | Financial Times
GSK's Emma Walmsley becomes highest-paid female FTSE 100 chief | GlaxoSmithKline | The Guardian
GSK delivers FY 2021 reported sales of £34 billion, stable at AER, +5% CER; Total EPS 87.6p -24% AER, -13% CER and Adjusted EPS of 113.2p -2% AER, +9% CER | GSK
GSK: cash flow 2022 | Statista
GSK Cuts Return to Shareholders From Novartis Asset Swap - WSJ
Is GSK A Good Choice For Dividend Investors? | Seeking Alpha
GSK (LSE:GSK) - Stock Price, News & Analysis - Simply Wall St
Glaxosmithkline Pharma Q1 Results: Net profit rises 8% to Rs 116 crore - The Economic Times
GlaxoSmithKline rewards CEO Walmsley with a 17% pay bump, to £8.2 million | Fierce Pharma
GlaxoSmithKline Deal for Tesaro: It's the Wrong Medicine - Bloomberg
GSK India reports Rs 133 crore net profit in quarter four of FY23 - The Economic Times
Will GlaxoSmithKline deal be worth it for Unilever?
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
Key player - GlaxoSmithKline
First female CEO of GSK to be paid 25% less than her male predecessor
GSK plc - Wikipedia
GlaxoSmithKline: 30% Undervalued And Spinoff To Drive Growth (NYSE:GSK) | Seeking Alpha
Why GSK should turn down Unilever's billions | MoneyWeek
Clouds Are Gathering (Again) For GSK | Seeking Alpha
GlaxoSmithKline CEO Walmsley's pay falls to $9.7M as pandemic drags on profits | Fierce Pharma
